Melisron Limited

As of June 30, 2026, Melisron Limited carries a market capitalization of 1.99T, placing it among publicly traded companies globally. Its enterprise value stands at 3.45T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Melisron Limited's next confirmed earnings release is scheduled for November 25, 2026.

As of June 30, 2026, Melisron Limited has 47.66M shares outstanding.

As of June 30, 2026, Melisron Limited trades at a trailing price-to-earnings ratio of 11.46. The price-to-sales ratio is 8.42, and the price-to-book ratio stands at 1.46.

As of June 30, 2026, Melisron Limited trades at an EV/EBITDA multiple of 22.54 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 14.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.81 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Melisron Limited trades at an EV/FCF ratio of 43.38, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 3.45T versus a market cap of 1.99T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Melisron Limited maintains a current ratio of 0.59, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 108.94, indicating elevated leverage, while an interest coverage ratio of 2.94 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Melisron Limited posted a return on equity (ROE) of 13.47, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.04 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.06, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.27, useful for judging operating efficiency across full business cycles. The company generates approximately 710.98M in revenue per employee across its workforce of 332.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.19 indicates how many times Melisron Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Melisron Limited recorded 51.20B in income tax expense. That works out to an effective tax rate of 22.38, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 228.80B, leaving 173.70B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Melisron Limited's stock has declined approximately 4.00% over the past 52 weeks. The 50-day moving average sits at 39,934.40, while the 200-day moving average is 42,089.45.

Over the twelve months ended June 30, 2026, Melisron Limited generated 236.40B in revenue and converted that into 173.70B in net income, yielding earnings per share of 3,725.13. EBITDA reached 153.10B, while operating income came in at 151.30B.

As of June 30, 2026, Melisron Limited holds 148.70B in cash and equivalents against 1.55T in total debt, resulting in a net debt position of 1.44T. Total book value stands at 1.36T, with working capital of -178.50B providing operational flexibility.

Melisron Limited produced 39.60B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -500.00M in capital expenditures, free cash flow totaled 39.10B - equivalent to 820.11 per share.

Over the twelve months ended June 30, 2026, Melisron Limited posted a gross margin of 69.33, reflecting its pricing power and cost economics. The operating margin of 64.00 and net profit margin of 73.48 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Melisron Limited paid dividends of 755.09 per share. The dividend payout ratio of 19.83 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 1.96, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.73, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Melisron Limited shareholders.

Melisron Limited's most recent stock split took place on August 30, 2011 with a 145:157 split ratio.

As of June 30, 2026, Melisron Limited has an Altman Z-Score of 1.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.